Trial Profile
Drug Use Investigation Of Gabapentin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2021
Price :
$35
*
At a glance
- Drugs Gabapentin (Primary)
- Indications Epilepsy
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 10 Jun 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Apr 2013 Planned end date changed from 1 Mar 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 13 May 2011 Planned End Date changed from 1 Dec 2009 to 1 Mar 2013 as reported by ClinicalTrials.gov.